CIGB-258 immunomodulatory peptide: a novel promising treatment for critical and severe COVID-19 patientsR Venegas-Rodriguez, Mónica Béquet‐Romero, Mabel Hernández-Cedeño et al.|medRxiv|2020Cited by 7
An immunomodulatory peptide CIGB-258 for the treatment of critical and severe COVID-19 patientsR. V. Rodríguez, M. C. Domínguez-Horta, Rosaura Ruiz et al.|Revista cubana de medicina militar|2020Cited by 0